The global clinical trial equipment & ancillary solutions market size is anticipated to reach USD 4.4 billion by 2028, according to the new report of Grand View Research, Inc., expanding at a CAGR of 8.2% over the forecast period. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market.
The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.
The COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of the equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were in progress before the pandemic have been halted, while many new trials have been launched in the hunt for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/clinical-trial-equipment-ancillary-solutions-market-report
Clinical Trial Equipment & Ancillary Solutions Market Report Highlights
• The supply/logistics product segment dominated the market with a revenue share of more than 38% in 2020 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
• The phase III segment accounted for the maximum revenue share of the global market in 2020. Phase III studies are the most effective approach to discover a new treatment standard
• North America led the global market in 2020 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region.
• Asia Pacific is projected to be the fastest-growing regional market during the forecast period as it is becoming an increasingly significant site for clinical trial investigations.
For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/clinical-trial-equipment-ancillary-solutions-market-report
Clinical Trial Equipment & Ancillary Solutions Market Segmentation
Grand View Research has segmented the clinical trial equipment & ancillary solutions market on the basis of product, phase, and region:
Clinical Trial Equipment & Ancillary Solutions Product Outlook (Revenue, USD Million, 2016 – 2028)
• Equipment Servicing
Clinical Trial Equipment & Ancillary Solutions Phase Outlook (Revenue, USD Million, 2016 – 2028)
• Phase I
• Phase II
• Phase III
• Phase IV
Clinical Trial Equipment & Ancillary Solutions Regional Outlook (Revenue, USD Million, 2016 – 2028)
• North America
• The U.S.
• The U.K.
• Asia Pacific
• South Korea
• Latin America
• Saudi Arabia
• South Africa
List of Key Players of Clinical Trial Equipment & Ancillary Solutions Market
• Ancillare, LP
• Imperial Clinical Research Services
• Woodley Equipment Company Ltd.
• Thermo Fisher Scientific, Inc.
• PPD, Inc.
• PAREXEL International Corp.
• MediCapital Rent
• Quipment SAS
Fill the Pre-Order Enquiry Form for the Report @ https://www.grandviewresearch.com/inquiry/451829/ibb
Browse Related Reports:
Non-alcoholic Steatohepatitis Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, II, III, IV), By Study Design (Interventional, Expanded Access), By Region (APAC, Europe), And Segment Forecasts, 2022 – 2030.
About Grand View Research
Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States